BlackRock, Inc. 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 5:28 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 5,743,482 6.800% | 1,044,711 (+22.23%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 4,698,771 5.600% | 0 (Unchanged) | Filing |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 4,698,771 5.600% | 1,577,906 (+50.56%) | Filing |
| 2024-06-07 1:30 pm Sale | 2024-05-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 3,120,865 4.800% | -288,113 (-8.45%) | Filing |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | BlackRock Inc. BLK | 3,408,978 5.500% | 3,408,978 (New Position) | Filing |